Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Hobberson Mar 15, 2013 10:46am
230 Views
Post# 21134961

RE: No more quessing.

RE: No more quessing.

 

New to the board and new to the stock thanks to a "check it out" heads-up from sinbob some time ago.

 

A few posts ago deadpatient remarked that "all is good" with BTI after talking to Cam Thindal of Hamza Thindal.  I checked out Hamza Thindal's website to find that the company is a capital corporation that invests in promising companies in several fields including healthcare/life sciences.   

 

They put over 1 million into BTI in 2010, another million plus in 2011 and roughly 

2.5 million in April of 2012. They've also put over over 1.7million into ICO in 2009 and another 1.1 million in 2011, for what that's worth.

 

It would be helpful, imo, if deadpatient could fill us in as to what he learned from his contact with the firm, especially since he spoke with one of the Thindals.

 

https://www.htcapitalcorp.com/s/Transactions.asp?Year=2012&DateRange=2012/01/01...2012/12/31

Bullboard Posts